301 related articles for article (PubMed ID: 36362045)
1. COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs.
Lee JH; Kanwar B; Khattak A; Balentine J; Nguyen NH; Kast RE; Lee CJ; Bourbeau J; Altschuler EL; Sergi CM; Nguyen TNM; Oh S; Sohn MG; Coleman M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362045
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling.
Shen S; Rui Y; Wang Y; Su J; Yu XF
J Med Virol; 2023 Jan; 95(1):e28220. PubMed ID: 36229923
[TBL] [Abstract][Full Text] [Related]
3. Treatment mechanism of immune triad from the repurposing drug against COVID-19.
Lee JH
Transl Med Aging; 2023; 7():33-45. PubMed ID: 37388715
[TBL] [Abstract][Full Text] [Related]
4. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
[TBL] [Abstract][Full Text] [Related]
5. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
Shen Q; Xu P; Mei C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
[TBL] [Abstract][Full Text] [Related]
6. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
[TBL] [Abstract][Full Text] [Related]
7. DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation.
Lou M; Huang D; Zhou Z; Shi X; Wu M; Rui Y; Su J; Zheng W; Yu XF
J Med Virol; 2023 Jan; 95(1):e28310. PubMed ID: 36377393
[TBL] [Abstract][Full Text] [Related]
8. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Berthelot JM; Lioté F; Maugars Y; Sibilia J
Front Immunol; 2020; 11():607069. PubMed ID: 33335532
[TBL] [Abstract][Full Text] [Related]
10. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Domizio JD; Gulen MF; Saidoune F; Thacker VV; Yatim A; Sharma K; Nass T; Guenova E; Schaller M; Conrad C; Goepfert C; de Leval L; Garnier CV; Berezowska S; Dubois A; Gilliet M; Ablasser A
Nature; 2022 Mar; 603(7899):145-151. PubMed ID: 35045565
[TBL] [Abstract][Full Text] [Related]
11. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy.
Han L; Zheng Y; Deng J; Nan ML; Xiao Y; Zhuang MW; Zhang J; Wang W; Gao C; Wang PH
J Med Virol; 2022 Nov; 94(11):5174-5188. PubMed ID: 35765167
[TBL] [Abstract][Full Text] [Related]
13. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Yu CH; Davidson S; Harapas CR; Hilton JB; Mlodzianoski MJ; Laohamonthonkul P; Louis C; Low RRJ; Moecking J; De Nardo D; Balka KR; Calleja DJ; Moghaddas F; Ni E; McLean CA; Samson AL; Tyebji S; Tonkin CJ; Bye CR; Turner BJ; Pepin G; Gantier MP; Rogers KL; McArthur K; Crouch PJ; Masters SL
Cell; 2020 Oct; 183(3):636-649.e18. PubMed ID: 33031745
[TBL] [Abstract][Full Text] [Related]
15. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
Liang L; Shen Y; Hu Y; Liu H; Cao J
PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
[TBL] [Abstract][Full Text] [Related]
16. HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR-181a-5p or KPNA2/cGAS-STING/IFN-I signaling.
Zhao L; Yuan H; Wang Y; Geng Y; Yun H; Zheng W; Yuan Y; Lv P; Hou C; Zhang H; Sun J; Sun L; Suo Y; Wang S; Zhang N; Lu W; Yang G; Zhang X
J Med Virol; 2023 Jul; 95(7):e28966. PubMed ID: 37466313
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and cellular functions of cGAS-STING signalling.
Hopfner KP; Hornung V
Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
[TBL] [Abstract][Full Text] [Related]
18. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.
Dai P; Wang W; Cao H; Avogadri F; Dai L; Drexler I; Joyce JA; Li XD; Chen Z; Merghoub T; Shuman S; Deng L
PLoS Pathog; 2014 Apr; 10(4):e1003989. PubMed ID: 24743339
[TBL] [Abstract][Full Text] [Related]
19. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).
Messaoud-Nacer Y; Culerier E; Rose S; Maillet I; Rouxel N; Briault S; Ryffel B; Quesniaux VFJ; Togbe D
Cell Death Dis; 2022 Mar; 13(3):269. PubMed ID: 35338116
[TBL] [Abstract][Full Text] [Related]
20.
Fischer K; Tschismarov R; Pilz A; Straubinger S; Carotta S; McDowell A; Decker T
Front Immunol; 2020; 11():571334. PubMed ID: 33178195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
